Uncategorised EVOcells Oncology: Tailored genetic engineering of iPSC-derived immune effector cells 28 March 2023 Learn more
Uncategorised VEGFR-3 Signature Expression by Histology to Classify Patient Populationfor the Selective VEGFR-3 Inhibitor EVT801 15 March 2023 Learn more
